Refine Your Results

Click below to filter your search results

"Guidelines"Undo

Search Results

Return to List
Results 81–100 of 221
Title Date
81.

Family History as a Risk Assessment Tool

Number 478

(Reaffirmed 2015)

ABSTRACT Family history plays a critical role in assessing the risk of inherited medical conditions and single gene disorders Several methods have been established to obtain family medical histories including the family history questionnaire or checklist and the pedigree The screening tool selecte...

March 2011

PDF Format
82.

Methamphetamine Abuse in Women of Reproductive Age

Number 479

(Reaffirmed 2013)

ABSTRACT Methamphetamine abuse has continued to increase in the United States since the late 1980s with its use spreading from the West Coast to areas across the country Methamphetamine use in pregnancy endangers the health of the woman and increases the risk of low birth weight and small for gest...

March 2011

PDF Format
83.

Empathy in Womens Health Care

Number 480

(Reaffirmed 2014)

ABSTRACT Empathy is the process through which one attempts to project oneself into anothers life and imagine a situation from his or her point of view Most individuals do have an innate capacity to show empathy toward others Empathy is as important to being a good physician as technical competence...

March 2011

PDF Format
84.

Performance Enhancing Anabolic Steroid Abuse in Women

Number 484

(Reaffirmed 2013)

ABSTRACT Anabolic steroids are composed of testosterone and other substances related to testosterone that promote growth of skeletal muscle increase hemoglobin concentration and mediate secondary sexual characteristics These substances have been in use since the 1930s to promote muscle growth impr...

April 2011

PDF Format
85.

Prevention of Early-Onset Group B Streptococcal Disease in Newborns

Number 485

(Replaces No. 279, December 2002, Reaffirmed 2015)

ABSTRACT In 2010 the Centers for Disease Control and Prevention revised its guidelines for the prevention of perinatal group B streptococcal disease Although universal screening at 3537 weeks of gestation and intrapartum antibiotic prophylaxis continue to be the basis of the prevention strategy th...

April 2011

PDF Format
86.

Update on Carrier Screening for Cystic Fibrosis

Number 486

(Reaffirmed 2014, Replaces No. 325, December 2005)

ABSTRACT In 2001 the American College of Obstetricians and Gynecologists and the American College of Medical Genetics introduced guidelines for prenatal and preconception carrier screening for cystic fibrosis The American College of Obstetricians and Gynecologists Committee on Genetics has updated...

April 2011

PDF Format
87.

Pharmacogenetics

Number 488

(Reaffirmed 2015)

ABSTRACT Pharmacogenetics is the study of genetic variations in drug response that are determined by specific genes It is hoped that the use of pharmacogenetics in clinical practice may improve drug safety and decrease the rate of adverse drug reactions Given the potential applications of pharmaco...

May 2011

PDF Format
88.

Partnering With Patients to Improve Safety

Number 490

(Reaffirmed 2013, Replaces No. 320, November 2005)

Abstract Actively involving patients in the planning of health services is recommended as a means of improving the quality of care This can increase patient engagement and reduce risk resulting in improved outcomes satisfaction and treatment adherence Introduction The foundation for a positive phy...

May 2011

PDF Format
89.

Cultural Sensitivity and Awareness in the Delivery of Health Care

Number 493

(Reaffirmed 2013)

ABSTRACT Communication with patients can be improved and patient care enhanced if health care providers can bridge the divide between the culture of medicine and the beliefs and practices that make up patients value systems These may be based on ethnic heritage nationality of family origin age rel...

May 2011

PDF Format
90.

Sulfonamides, Nitrofurantoin, and Risk of Birth Defects

Number 494

Reaffirmed 2013

Abstract The evidence regarding an association between the nitrofuran and sulfonamide classes of antibiotics and birth defects is mixed As with all patients antibiotics should be prescribed for pregnant women only for appropriate indications and for the shortest effective duration During the secon...

June 2011

PDF Format
91.

Vitamin D: Screening and Supplementation During Pregnancy

Number 495

ABSTRACT During pregnancy severe maternal vitamin D deficiency has been associated with biochemical evidence of disordered skeletal homeostasis congenital rickets and fractures in the newborn At this time there is insufficient evidence to support a recommendation for screening all pregnant women f...

July 2011

PDF Format
92.

At-Risk Drinking and Alcohol Dependence: Obstetric and Gynecologic Implications

Number 496

(Reaffirmed 2013)

ABSTRACT Compared with men atrisk alcohol use by women has a disproportionate effect on their health and lives including reproductive function and pregnancy outcomes Obstetriciangynecologists have a key role in screening and providing brief intervention patient education and treatment referral for...

August 2011

PDF Format
93.

Adult Manifestations of Childhood Sexual Abuse

Number 498

(Reaffirmed 2013)

ABSTRACT Longterm effects of childhood sexual abuse are varied complex and often devastating Many obstetriciangynecologists knowingly or unknowingly provide care to abuse survivors and should screen all women for a history of such abuse Depression anxiety and anger are the most commonly reported e...

August 2011

PDF Format
94.

Professional Responsibilities in Obstetric-Gynecologic Medical Education and Training

Number 500

(Reaffirmed 2014, Replaces No. 358, January 2007)

ABSTRACT The education of health care professionals is essential to maintaining standards of medical competence and access to care by patients Inherent in the education of health care professionals is the problem of disparity in power and authority including the power of teachers over learners and...

August 2011

PDF Format
95.

Maternal-Fetal Intervention and Fetal Care Centers

Number 501

(Reaffirmed 2014)

ABSTRACT The past two decades have yielded profound advances in the fields of prenatal diagnosis and fetal intervention Although fetal interventions are driven by a beneficencebased motivation to improve fetal and neonatal outcomes advancement in fetal therapies raises ethical issues surrounding m...

August 2011

PDF Format
96.

Tobacco Use and Women's Health

Number 503

(Reaffirmed 2013)

ABSTRACT Tobacco use negatively affects every organ system and is the most prevalent cause of premature death for adults within the United States Compared with women who are nonsmokers women who smoke cigarettes have greater risks of reproductive health problems many forms of gynecologic cancer an...

September 2011

PDF Format
97.

Understanding and Using the U.S. Medical Eligibility Criteria for Contraceptive Use, 2010

Number 505

(Reaffirmed 2014)

ABSTRACT The 2010 US Medical Eligibility Criteria for Contraceptive Use US MEC issued by the Centers for Disease Control and Prevention gives comprehensive evidencebased guidance to clinicians providing family planning services to women especially women with medical conditions The American College...

September 2011

PDF Format
98.

Human Trafficking

Number 507

ABSTRACT Human trafficking is a widespread problem with estimates ranging from 14000 to 50000 individuals trafficked into the United States annually This hidden population involves the commercial sex industry agriculture factories hotel and restaurant businesses domestic workers marriage brokers a...

September 2011

PDF Format
99.

Disruptive Behavior

Number 508

(Reaffirmed 2013, Replaces No. 366, May 2007)

ABSTRACT Disruptive physician behavior may have a negative effect on patient care Consequently it is important that a systematic process be in place to discourage identify and remedy episodes of disruptive behavior Introduction A growing number of organizations recognize that disruptive behavior m...

October 2011

PDF Format
100.

Management of Vulvar Intraepithelial Neoplasia

Number 509

(Reaffirmed 2014)

ABSTRACT Vulvar intraepithelial neoplasia VIN is an increasingly common problem particularly among women in their 40s The term VIN is used to denote highgrade squamous lesions and is subdivided into usualtype VIN including warty basaloid and mixed VIN and differentiated VIN Usualtype VIN is common...

November 2011

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998